Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)

NCT02702960 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped This study was withdrawn due to lack of necessary resources from the liver transplant surgical group.

Conditions

Fibrolamellar Hepatocellular Carcinoma
Hepatocellular Carcinoma (Fibrolamellar Variant)
Hepatocellular Carcinoma

Interventions

PROCEDURE: living related donor partial liver transplantation
RADIATION: Total body irradiation
PROCEDURE: Bone marrow transplant from same donor
DRUG: Cyclophosphamide
DRUG: Mesna
DRUG: Filgrastim
DRUG: Tacrolimus
DRUG: mycophenolate mofetil
DRUG: Prednisone
DRUG: Antithymocyte globulin
DRUG: fludarabine

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]